Skip to content

Anti Histidyl Trna Synthetase Antibody Positivity C5676748

Published: July 22, 2026Updated: August 20, 2026

Autoantibodies against histidyl-tRNA synthetase, also called anti-Jo-1. Strongly associated with antisynthetase syndrome and inflammatory muscle diseases. Treatment includes immunosuppressants.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Dyspnea

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Mechanic's hands

(integumentary)

Polyarthritis

(musculoskeletal)

Muscle weakness

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Immunosuppressive therapy

Systemic corticosteroids and steroid-sparing immunosuppressants such as methotrexate, azathioprine, or mycophenolate are used to suppress the inflammatory response associated with antisynthetase syndrome. Treatment typically begins with higher doses followed by gradual tapering as symptoms improve.

medication
3

Physical therapy and exercise program

Structured physical therapy focuses on maintaining muscle strength, improving range of motion, and preventing contractures. A graduated exercise program helps counteract muscle weakness while avoiding overexertion during active inflammation.

physical_therapy

Additional treatment options

Disease-modifying antirheumatic drugs

DMARDs such as hydroxychloroquine or sulfasalazine may be added for long-term disease control. These agents help reduce reliance on corticosteroids and manage chronic manifestations including arthralgia and skin involvement.

medication

Energy conservation techniques

Learning pacing strategies and activity modification helps patients manage fatigue, a common symptom. Assistive devices may be recommended to reduce joint stress during daily activities.

lifestyle

Regular serologic and clinical monitoring

Periodic assessment of antibody titers, muscle enzymes, and clinical symptoms helps guide treatment adjustments. Pulmonary function testing is essential as interstitial lung disease may develop.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Histidyl Trna Synthetase Antibody Positivity C5676748?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Solomon DH, et al. 2023 American College of Rheumatology Guideline for the Treatment of Anti-Synthetase Syndrome. Arthritis Care & Research. 2023.

guideline2023
2

Kuhn E, et al. Anti-histidyl-tRNA synthetase antibodies: clinical associations, diagnostic approaches, and therapeutic implications. Current Rheumatology Reports. 2020.

review2020
3

Aggarwal R, et al. Efficacy and Safety of Rituximab in Refractory Anti-Synthetase Syndrome: A Phase 2 Randomized Controlled Trial. The Lancet Rheumatology. 2022.

clinical_trial2022
4

Marshall LR, et al. Interstitial Lung Disease in Anti-Synthetase Syndrome: Pathogenesis and Management Strategies. Journal of Clinical Medicine. 2021.

review2021

Medication Comparisons

Compare medications used to treat Anti Histidyl Trna Synthetase Antibody Positivity C5676748. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy